| Typicality: | 0.561 |
| Saliency: | 0.426 |
| unanimously | 8 | manner |
| as a biosimilar product to remicade | 5 | transitive-object |
| with little discussion | 4 | manner |
| committee → vote in → favor | 44 |
| committee → vote in → favour | 17 |
| committee → vote in → support | 3 |
| negative | neutral | positive |
| 0.058 | 0.684 | 0.258 |
| Raw frequency | 64 |
| Normalized frequency | 0.426 |
| Modifier score | 0.900 |
| Perplexity | 95.789 |